Study details
Enrolling now
Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment
University of Kansas Medical Center
NCT IDNCT05732272ClinicalTrials.gov data as of Apr 2026
Phase
Phase 3
Target enrollment
500
Study length
about 4.1 years
Ages
18+
Locations
1 site in MO
What this study is about
This trial is testing whether extended bupropion treatment helps African American smokers quit. It compares 6 months of bupropion to a standard 7 week course, with counseling support for all participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Bupropion
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized (Open Label)
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
bupropion